Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension
JAMA Network Open · 2024
DOI: 10.1001/jamanetworkopen.2024.34644 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Network Open, 2024. Verfasst von John Granton und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, Faculty of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Acetamides, Pyrazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Respirology, Faculty of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
- Cardiology, Royal Free London NHS Foundation Trust, London, United Kingdom.
Zitieren
APA
Granton, J., & Coghlan, G. (2024). Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.34644
Vancouver
Granton J, Coghlan G. Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.34644
BibTeX
@article{Granton2024,
author = {Granton, John and Coghlan, Gerry},
title = {Novel Approach to Evaluate the Role of Selexipag in Pulmonary Arterial Hypertension},
journal = {JAMA Network Open},
year = {2024},
doi = {10.1001/jamanetworkopen.2024.34644}
}
EUVIMED